We are live on !
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
Turnover
40.17%
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow % of AUM
Cap. Flow %
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
2.3
years
Top 20 Avg Time Held
Equity + Options
1.6
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.9B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1926
NCR Atleos
NATL
$3.47B
| $1.68M | ﹤0.01% |
38,600
+1,400
| +4% | +$62.1K |
2025 Q4
2 quarters
|
|
1927
Viking Therapeutics
VKTX
$3.08B
| $1.67M | ﹤0.01% |
42,767
-47,593
| -53% | -$1.54M |
2026 Q1
1 quarter
|
|
1928
Church & Dwight Co
CHD
$25B
| $1.67M | ﹤0.01% |
+17,216
| New | +$1.65M |
2026 Q2
0 quarters
|
|
1929
Bridger Aerospace
BAER
$27.2M
| $1.67M | ﹤0.01% |
868,374
-153,150
| -15% | -$303K |
2024 Q4
6 quarters
|
|
1930
Duke Energy
DUK
$97B
| $1.66M | ﹤0.01% |
13,149
-879,020
| -99% | -$111M |
2025 Q4
2 quarters
|
|
1931
Black Diamond Therapeutics
BDTX
$97.1M
| $1.66M | ﹤0.01% |
896,602
+60,336
| +7% | +$148K |
2025 Q2
4 quarters
|
|
1932
TriplePoint Venture Growth BDC
TPVG
$175M
| $1.66M | ﹤0.01% |
337,655
-59,134
| -15% | -$317K |
2024 Q2
8 quarters
|
|
1933
ProPetro Holding
PUMP
$900M
| $1.66M | ﹤0.01% |
+115,443
| New | +$1.79M |
2026 Q2
0 quarters
|
|
1934
Jakks Pacific
JAKK
$366M
| $1.65M | ﹤0.01% |
71,034
+483
| +0.7% | +$10.7K |
2026 Q1
1 quarter
|
|
1935
National Bankshares
NKSH
$259M
| $1.65M | ﹤0.01% |
45,503
+26,004
| +133% | +$938K |
2026 Q1
1 quarter
|
|
1936
CALL
Berkshire Hathaway Class B
BRK.B
$1.17T
| $1.65M | ﹤0.01% |
3,300
-3,300
| -50% | -$1.59M |
2021 Q4
18 quarters
|
|
1937
Invesco S&P 100 Equal Weight ETF
EQWL
$2.84B
| $1.64M | ﹤0.01% |
+12,714
| New | +$1.58M |
2026 Q2
0 quarters
|
|
1938
CVR Energy
CVI
$6.23B
| $1.64M | ﹤0.01% |
59,420
-46,505
| -44% | -$1.48M |
2026 Q1
1 quarter
|
|
1939
Pathward Financial
CASH
$1.63B
| $1.64M | ﹤0.01% |
18,788
+11,388
| +154% | +$985K |
2026 Q1
1 quarter
|
|
1940
Fortuna Silver Mines
FSM
$2.75B
| $1.62M | ﹤0.01% |
192,116
-138,163
| -42% | -$1.34M |
2026 Q1
1 quarter
|
|
1941
Bowman Consulting
BWMN
$711M
| $1.62M | ﹤0.01% |
55,461
-106,130
| -66% | -$3.34M |
2024 Q1
9 quarters
|
|
1942
North European Oil Royalty Trust
NRT
$79.1M
| $1.62M | ﹤0.01% |
220,995
-90,847
| -29% | -$734K |
2025 Q4
2 quarters
|
|
1943
Immunic
IMUX
$99.3M
| $1.61M | ﹤0.01% |
104,816
+9,519
| +10% | +$117K |
2023 Q3
11 quarters
|
|
1944
Phreesia
PHR
$783M
| $1.61M | ﹤0.01% |
156,102
+101,275
| +185% | +$940K |
2023 Q4
10 quarters
|
|
1945
Rush Enterprises Class A
RUSHA
$5.29B
| $1.61M | ﹤0.01% |
+33,009
| New | +$1.55M |
2026 Q2
0 quarters
|
|
1946
LoveSac
LOVE
$220M
| $1.6M | ﹤0.01% |
96,136
-99,166
| -51% | -$1.57M |
2026 Q1
1 quarter
|
|
1947
Huntsman Corp
HUN
$1.56B
| $1.6M | ﹤0.01% |
151,030
-370,650
| -71% | -$5.11M |
2024 Q1
9 quarters
|
|
1948
New Horizon Aircraft
HOVR
$85.2M
| $1.6M | ﹤0.01% |
813,610
+716,497
| +738% | +$1.53M |
2025 Q4
2 quarters
|
|
1949
Surgery Partners
SGRY
$3.04B
| $1.6M | ﹤0.01% |
95,362
+82,536
| +644% | +$1.16M |
2025 Q3
3 quarters
|
|
1950
Vanguard High Dividend Yield ETF
VYM
$82.7B
| $1.6M | ﹤0.01% |
+10,100
| New | +$1.58M |
2026 Q2
0 quarters
|
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.